19 U.S. lawmakers have disclosed 49 Allergan plc trades under the STOCK Act — 27 buys and 20 sells between 2015 and 2020. Congress has been net buyers of AGN.
*Notional-weighted price return on lawmakers' disclosed buys of AGN, marked to the latest close — per-share (share counts aren't disclosed).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2020-05-18 | Gilbert Cisneros | SELL | $1K–$15K | — | — | — exit |
| 2020-05-11 | Joseph D. Morelle | exchange | $1K–$15K | — | — | — |
| 2020-05-08 | Steve Chabot | BUY | $1K–$15K | — | — | — |
| 2020-04-14 | Kelly Loeffler | SELL | $250K–$500K | — | — | — exit |
| 2020-03-30 | Robert J. Wittman | SELL | $1K–$15K | — | — | — exit |
| 2020-02-28 | Earl Blumenauer | SELL | $1K–$15K | — | — | — exit |
| 2019-02-08 | Rohit Khanna | BUY | $1K–$15K | — | — | — |
| 2019-01-24 | Rohit Khanna | BUY | $1K–$15K | — | — | — |
| 2018-11-28 | John F Reed | SELL | $1K–$15K | — | — | — exit |
| 2018-07-17 | Earl Blumenauer | BUY | $1K–$15K | — | — | — |
| 2018-06-05 | Lamar Smith | SELL | $1K–$15K | — | — | — exit |
| 2018-04-27 | Thomas J. Rooney | SELL | $15K–$50K | — | — | — exit |
| 2018-02-28 | Thomas J. Rooney | SELL | $1K–$15K | — | — | — exit |
| 2018-02-28 | Earl Blumenauer | BUY | $1K–$15K | — | — | — |
| 2018-02-22 | James M Inhofe | SELL | $50K–$100K | — | — | — exit |
| 2017-12-21 | John A. Yarmuth | SELL | $1K–$15K | — | — | — exit |
| 2017-12-08 | Thomas J. Rooney | SELL | $15K–$50K | — | — | — exit |
| 2017-12-07 | DIANNE FEINSTEIN | SELL | $1K–$15K | — | — | — exit |
| 2017-11-09 | John A. Yarmuth | SELL | $1K–$15K | — | — | — exit |
| 2017-10-23 | John F Reed | SELL | $1K–$15K | — | — | — exit |
| 2017-03-14 | Pete Sessions | SELL | $1K–$15K | — | — | — exit |
| 2017-03-06 | John F Reed | BUY | $1K–$15K | — | — | — |
| 2017-03-06 | John F Reed | BUY | $1K–$15K | — | — | — |
| 2017-02-14 | James M Inhofe | SELL | $50K–$100K | — | — | — exit |
| 2016-10-13 | Richard L. Hanna | SELL | $15K–$50K | — | — | — exit |
| 2016-09-13 | James M Inhofe | BUY | $15K–$50K | — | — | — |
| 2016-08-26 | Alan S. Lowenthal | SELL | $15K–$50K | — | — | — exit |
| 2016-08-17 | K. Michael Conaway | BUY | $1K–$15K | — | — | — |
| 2016-08-16 | Lamar Smith | BUY | $1K–$15K | — | — | — |
| 2016-07-21 | James M Inhofe | BUY | $50K–$100K | — | — | — |
| 2016-05-06 | Ed Whitfield | BUY | $1K–$15K | — | — | — |
| 2016-02-01 | John A. Yarmuth | BUY | $1K–$15K | — | — | — |
| 2016-01-22 | K. Michael Conaway | SELL | $1K–$15K | — | — | — exit |
| 2015-12-01 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-12-01 | John A. Yarmuth | BUY | $1K–$15K | — | — | — |
| 2015-11-24 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-11-23 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-11-12 | James B. Renacci | SELL | $1K–$15K | — | — | — exit |
| 2015-11-12 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-10-21 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-10-09 | Alan S. Lowenthal | BUY | $1K–$15K | — | — | — |
| 2015-09-30 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-08-25 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-07-24 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-07-20 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-07-17 | James B. Renacci | BUY | $1K–$15K | — | — | — |
| 2015-03-17 | Richard L. Hanna | exchange | $15K–$50K | — | — | — |
| Rohit Khanna | BUY | $1K–$15K | — | — | — | |
| James M Inhofe | BUY | $15K–$50K | — | — | — |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
19 members of the U.S. House and Senate have disclosed Allergan plc transactions under the STOCK Act — 27 purchases and 20 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a AGN purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Every AGN trade is marked to the latest close in the Return column; sells matched to a prior buy show a realized round-trip return.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded AGN and how it performed.